Sentences with phrase «over other financial products»

Their primary sales advantage over other financial products was higher advisor compensation, and these types of compensation differentials will be easy pickings for class - action suits.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Apple Watch accounted for «well over» 100 percent of the sequential growth of «other products» and more than offset decline in iPods and accessories, Luca Maestri, Apple's chief financial officer, said during a call with analysts.

In that report, the CFPB said it had received more than 13,000 complaints over the last six months related to mortgages, credit cards, and other financial products.

These risks and uncertainties include food safety and food - borne illness concerns; litigation; unfavorable publicity; federal, state and local regulation of our business including health care reform, labor and insurance costs; technology failures; failure to execute a business continuity plan following a disaster; health concerns including virus outbreaks; the intensely competitive nature of the restaurant industry; factors impacting our ability to drive sales growth; the impact of indebtedness we incurred in the RARE acquisition; our plans to expand our newer brands like Bahama Breeze and Seasons 52; our ability to successfully integrate Eddie V's restaurant operations; a lack of suitable new restaurant locations; higher - than - anticipated costs to open, close or remodel restaurants; increased advertising and marketing costs; a failure to develop and recruit effective leaders; the price and availability of key food products and utilities; shortages or interruptions in the delivery of food and other products; volatility in the market value of derivatives; general macroeconomic factors, including unemployment and interest rates; disruptions in the financial markets; risk of doing business with franchisees and vendors in foreign markets; failure to protect our service marks or other intellectual property; a possible impairment in the carrying value of our goodwill or other intangible assets; a failure of our internal controls over financial reporting or changes in accounting standards; and other factors and uncertainties discussed from time to time in reports filed by Darden with the Securities and Exchange Commission.

CDs currently compare poorly to the returns on other financial products, and with the Fed planning on a slow increase to the funds rate over 2017, you may lose out from locking your money into a CD too early.

Experience led me to create Profit.ly, a community of over 84,000 traders who share their performance and trades openly to help each other learn & improve and Investimonials.com, a community of over 65,000 investors & traders who have reviewed over 25,000 financial products Frequency - about 3 posts per week

Experience led me to create Profit.ly, a community of over 84,000 traders who share their performance and trades openly to help each other learn & improve and Investimonials.com, a community of over 65,000 investors & traders who have reviewed over 25,000 financial products Frequency about 6 posts per week.

Online lenders provide not only the most convenient unsecured loans in the financial sector, they also offer the lowest rates, due to low company overhead and stiff online competition with other financial institutions that market their products on the Internet, both of which can add up to significant savings for you over the term of your new loan.

In my humble opinion as someone who is now debt free (except the mortgage) after having over $ 90,000 of consumer debt, I do not think it is a good idea to invest in a brokerage account, money market, annuity, or any other financial product until your consumer debt is paid off.

A financial product issued by banks and other financial institutions that lets investors buy shares (or other securities) over a period of time, making an initial payment and paying the balance later.

ETFs have grown faster than any other financial product, total AuM surpassed that of hedge funds1last year and currently stands at over $ 3trn2.

Experience led me to create Profit.ly, a community of over 84,000 traders who share their performance and trades openly to help each other learn & improve and Investimonials.com, a community of over 65,000 investors & traders who have reviewed over 25,000 financial products Frequency about 5 posts per week.

That's partly because it recently launched Oaken Financial, which offers savings accounts and other banking products, mainly over the Internet.

If you value any one specific quality over the others, you will likely find a better option in a more specialized financial product.

Experience led me to create Profit.ly, a community of over 84,000 traders who share their performance and trades openly to help each other learn & improve and Investimonials.com, a community of over 65,000 investors & traders who have reviewed over 25,000 financial products Frequency about 6 posts per week.

Credit unions have branches in over 100 communities throughout the province, thereby providing Manitobans substantially better physical access to high quality financial services and products than any other financial institution.

Other practices will only be per - mitted if subject to a clear and unambiguous upfront agreement between the parties: a buyer returning unsold food products to a supplier; a buyer charging a supplier payment to se - cure or maintain a supply • Increased powers for Fi - nancial Intelligence Units (FIUs): FIUs will have ac - cess to information in cen - tralised banks and pay - ment account registers to strengthen the identifica - tion of account holders Whilst the directive applies to all financial institutions, its enforcement will spill over into adjacent indus - tries and actors including auditors, notaries, estate agents and casinos, ac - cording to LexisNexis ® Risk Solutions.

Not only consumers, financial experts are always in favor of term insurance plans over any other insurance products.

Being able to garner the loyalty of new users could give the company a significant advantage over its competitors, as successful new traders will be likely to trade other financial products offered by Ayondo.

To become a skillful, honest and brilliant stockbroker in any stock broking company where I can use my over 5 years of experience in capital investments, securities, and several other financial products on behalf of private, corporate, and institutional clients.

Extensive knowledge of banking products and services, as well as business development and... lending programs, deposit products and other financial services are designed to meet the needs of the communities... Professional Summary Results - oriented banking professional with over 30 years in sales and branch

Experience led me to create Profit.ly, a community of over 84,000 traders who share their performance and trades openly to help each other learn & improve and Investimonials.com, a community of over 65,000 investors & traders who have reviewed over 25,000 financial products Frequency about 6 posts per week.

More than 80 percent of about 1,000 homeowners recently surveyed said that they believe the value of their home will increase over the next three years as well as over the next five years, according to a new study by LendEDU, a marketplace for student loans, credit cards, and other financial products.